<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24">
 <label>24</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Haga</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Nagata</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Okamura</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Yamamoto</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Sata</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Yamamoto</surname>
    <given-names>N</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds</article-title>
  <source xml:lang="en">Antiviral Res</source>
  <year>2010</year>
  <volume>85</volume>
  <issue>(3)</issue>
  <fpage>551</fpage>
  <lpage>5</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2009.12.001</pub-id>
  <pub-id pub-id-type="pmid">19995578</pub-id>
 </element-citation>
</ref>
